Company Filing History:
Years Active: 2018
Title: Vishal Khairnar: Innovator in Immunotherapy
Introduction
Vishal Khairnar is a prominent inventor based in Essen, Germany. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on antibodies.
Latest Patents
Khairnar holds a patent for an immunostimulatory anti-CEACAM1 antibody. This invention includes at least one antibody heavy chain (V) domain with antigen binding sites CDR1, CDR2, and CDR3. Additionally, it features at least one antibody light chain (V) domain with the same antigen binding sites. Notably, the antigen binding site CDR2 has a sequence homology of at least 80% to the amino acid sequence WINTYTGEPT (SEQ ID No. 21). This patent showcases his expertise in developing targeted therapies that can enhance immune responses.
Career Highlights
Vishal Khairnar is affiliated with the University of Duisburg-Essen, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in treating various diseases.
Collaborations
Khairnar collaborates with esteemed colleagues, including Karl Lang and Bernhard Singer. Their combined efforts contribute to the advancement of research in the field of immunotherapy.
Conclusion
Vishal Khairnar is a notable inventor whose work in immunotherapy is paving the way for innovative treatments. His patent on the anti-CEACAM1 antibody exemplifies his commitment to enhancing immune responses.